SCHEMBL839121

SCHEMBL839121

CC(/N=N/c1cccc[n+]1CCO)=N\N=c1/ccccn1CCO

nearest known ligand 0.32

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
PABPC1 P11940 2/20 0.31
KDM4E B2RXH2 1/20 0.31
NPC1 O15118 1/20 0.31
APOBEC3A P31941 1/20 0.31
RAB9A P51151 1/20 0.31
APOBEC3G Q9HC16 1/20 0.31
POLB P06746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL483865 1.00 CA1 (0.32) CA1CA2PABPC1KDM4ENPC1
Hydrochloric Acid SCHEMBL1152259 0.99 CA1 (0.31) CA1CA2PABPC1KDM4ENPC1
Hydrochloric Acid SCHEMBL1152262 0.99 CA1 (0.31) CA1CA2PABPC1KDM4ENPC1
Hydrochloric Acid SCHEMBL5228745 0.91 CA1 (0.32) CA1CA2PABPC1KDM4ENPC1
SCHEMBL5196751 0.87 PABPC1 (0.31) CA1CA2PABPC1KDM4ENPC1
SCHEMBL21927056 0.87 KDM4E (0.32) PABPC1KDM4ENPC1APOBEC3ARAB9A
SCHEMBL839455 0.87 KDM4E (0.42) CA1CA2PABPC1KDM4ENPC1
Hydrochloric Acid SCHEMBL4804844 0.86 POLB (0.31) CA1CA2PABPC1POLB
Hydrochloric Acid SCHEMBL4803994 0.85
SCHEMBL14104303 0.85 CA1 (0.31) CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 161 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3544576-B1 DYE COMPOSITION COMPRISING 12-HYDROXYSTEARIC ACID, AN ORGANIC AMINE AND A DYE OREAL (FR) 2021-08-18 EP disclosed
WO-2021130088-A1 COSMETIC COMPOSITION COMPRISING A POLYMER COMPRISING AT LEAST ONE CATIONIC (METH)ACRYLAMIDE UNIT, A PARTICULAR SILICONE AND AT LEAST ONE SURFACTANT L'OREAL (FR) 2021-07-01 WO disclosed
EP-3393441-B1 DYEING COMPOSITION COMPRISING A DIRECT DYE OF TRIARYLMETHANE STRUCTURE, AND A SILICONE OREAL (FR) 2021-01-20 EP disclosed
WO-2018096132-A1 DYE COMPOSITION COMPRISING 12-HYDROXYSTEARIC ACID, AN ORGANIC AMINE AND A DYE L'OREAL (FR) 2018-05-31 WO disclosed
EP-2333018-B1 Dying composition comprising a particular disulfide dye and process of dying keratinous fibres with this dye L'ORÉAL (FR) 2017-11-22 EP disclosed
EP-2198843-B1 Lightening of human keratinic fibers with a anhydrous composition comprising a mixture of monoethanolamine/basic amine acid and kit L'ORÉAL (FR) 2017-09-13 EP disclosed
EP-2198833-B1 Method of coloring or lightening of human keratinic fibers with an anhydrous composition and an inorganic base and kit L'ORÉAL (FR) 2017-07-26 EP disclosed
WO-2017109182-A1 COMPOSITION COMPRISING AT LEAST TWO DIFFERENT STARCHES AND A COLOURING AGENT L'OREAL (FR) 2017-06-29 WO disclosed
EP-2198924-B1 METHOD FOR DYEING KERATIN MATERIALS IN THE PRESENCE OF AN EMULSION COMPRISING A DYE AND AN ALKALINE AGENT, AND AN OXIDISING COMPOSITION L'ORÉAL (FR) 2017-05-24 EP disclosed
EP-2198831-B1 Method for lightening, lightening direct dyeing or oxidation dyeing carried out in the presence of an organic amine and a mineral base; suitable kit L'ORÉAL (FR) 2017-05-10 EP disclosed
US-7288122-B2 Cationic diazo compounds, compositions comprising them as direct dye, process for dyeing keratin fibers and device therefor L'OREAL S.A. (FR) 2007-10-30 US disclosed
US-7288120-B2 Synthesis of tetraazapentamethine compounds, and processes for dyeing keratin fibers using this synthesis L'OREAL S.A. (FR) 2007-10-30 US disclosed
US-7285138-B2 Cationic diazo compound, compositions comprising at least one cationic diazo compound as a direct dye, a process for dyeing keratin fibers and device therefore L'OREAL, S.A. (FR) 2007-10-23 US disclosed
US-7282069-B2 Cationic diazo compounds, compositions comprising them as direct dye, process for dyeing keratin fibers and device therefor L'OREAL S.A. (FR) 2007-10-16 US disclosed
WO-2007110530-A2 SPECIFIC DYES OF NAPHTHALIMIDE TYPE, DYEING COMPOSITION COMPRISING AT LEAST ONE SUCH DYE, METHOD OF IMPLEMENTATION AND USES L'OREAL (FR) 2007-10-04 WO disclosed
US-7247713-B2 Symmetrical diazo compounds containing 2-pyridinium groups and cationic or non-cationic linker, compositions comprising them, method of coloring, and device L'OREAL, S.A. (FR) 2007-07-24 US disclosed
US-7208586-B2 Cationic diazo compounds, compositions comprising them as direct dye, process for dyeing keratin fibers and device therefor L'OREAL S.A. (FR) 2007-04-24 US disclosed
US-20070044250-A1 Cationic azo dyes with julolidine units, dyeing composition containing them, method of dyeing L'OREAL S.A. (FR) 2007-03-01 US disclosed
EP-1757264-A2 Cationic julolidine comprising azo compounds, dyeing compositions and process for dyeing keratin fibres L'Oréal (FR) 2007-02-28 EP disclosed
US-20070010663-A1 Dissymmetrical diazo compounds containing having at least one 2-imidazolium unit and a cationic or non-cationic linker, compositions comprising them, method of coloring, and device L'OREAL S.A. (FR) 2007-01-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070044250-A1 Cationic azo dyes with julolidine units, dyeing composition containing them, method of dyeing KRT18, IK, ACR CA1 1122/4885CA2 969/4885PABPC1 2323/4885
US-20070010663-A1 Dissymmetrical diazo compounds containing having at least one 2-imidazolium unit and a cationic or non-cationic linker, compositions comprising them, method of coloring, and device KRT18, DSP, DSG1 CA1 800/4885CA2 492/4885PABPC1 2449/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.